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extending the length of hospital stay and 
causing additional discomfort and pain to 
the patient. The Centers for Disease Con-
trol and Prevention (CDC) have released 
a publication, which details that the esti-
mated cost of hospital-acquired infec-
tions (HAIs) to US hospitals ranges up to 
$ 45 billion for inpatient hospital ser-
vices  [ 1 ]   and in 2011, ca. 75 000 hospitalized 
patients with HAIs died.  [ 2 ]   However, many 
of these infections are preventable and 
effective infection control interventions 
can save US healthcare institutions up to 
$ 31.5 billion.  [ 1 ]   
  One strategy to minimize the spread 
of infection is the use of antimicrobial 
surfaces.  [ 3 ]   Many such materials have 
been prepared for both hard and soft 
surfaces, for example, the use of micro-
biocide releasing surfaces,  [ 4,5 ]   silver-ion 
technology,  [ 6,7 ]   copper surfaces,  [ 8–13 ]   or sur-
faces covalently attached to peptides.  [ 14–16 ]  
One slightly different approach involves the photosensitization 
of bacteria. Light-activated antimicrobial hard surfaces, such 
as those coated with titania or doped titania thin ﬁ  lms,  [ 17–20 ]   or 
photobactericidal polymers, embedded with photosensitizer 
dyes,  [ 21–31 ]   exhibit potent light-activated antimicrobial activity. 
  Visible light photoactive antimicrobial surfaces including 
titania, silver-loaded titania, nitrogen-doped titania, and silver-
loaded nitrogen-doped titania thin ﬁ  lms, on glass surfaces have 
been developed.  [ 17,19 ]   Under white lighting conditions (12 h 
irradiation), titania coatings demonstrate negligible antimicro-
bial activity when tested against EMRSA-16.  [ 17 ]   Since titania is 
a UV-active photocatalyst, this poor photoactivity can be attrib-
uted to the limited proportion of UV light present in the white 
light source  [ 17 ]   and therefore, these materials are not suitable 
for white light-activated touch surface applications. Silver-doped 
titania-coatings have shown an enhanced photocatalytic effect, 
reducing bacterial numbers by ca. 2.5 log.  [ 17 ]   Moreover, when 
tested against   E. coli  , these samples demonstrate efﬁ  cacious 
bacterial kills, even under dark conditions, reducing bacterial 
numbers to below the detection limit within 6 h.  [ 17 ]   Similarly, 
silver-loaded nitrogen-doped titania samples also demonstrate 
enhanced light-activated kill rates compared to titania coatings, 
reducing bacterial levels to below the detection limit within 
5 h at a light ﬂ  uence of 1000 lx, although less efﬁ  cacious anti-
microbial activity was noted under dark conditions.  [ 19 ]   When 
tested against MRSA however, these samples only affected a 
2 log reduction in bacterial numbers upon irradiation for 5 h.  [ 19 ]  
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  1.      Introduction 
    Despite rigid hygiene protocols in place, the transfer of bacteria 
within hospital environments is a substantial issue and can lead 
to the contraction of healthcare-associated infection. Increas-
ingly, these outbreaks are caused by multidrug-resistant bac-
teria and can be extremely difﬁ  cult to treat, often signiﬁ  cantly 
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  Light-activated antimicrobial polymeric surfaces can be pre-
pared using a simple “swell-encapsulation-shrink” strategy to 
incorporate photosensitizer dye molecules into medical-grade 
polymers,  [ 23–27 ]   and this method can be upscaled for commer-
cial production. Illumination of dye-incorporated polymers pro-
motes the dye molecule to an excited triplet state, via intersystem 
crossing from the photoexcited dye singlet state.  [ 32 ]   The triplet 
state interacts with surrounding molecules such as molecular 
oxygen, generating reactive oxygen species that initiate a non-
site speciﬁ  c attack against bacteria in the vicinity, causing oxida-
tive damage and resulting in cell death.  [ 26 ]   Due to the multiple 
mechanisms of microbial attack induced by a range of pho-
togenerated reactive oxygen species, the emergence of resistance 
to this antimicrobial strategy is unlikely.  [ 33 ]   These materials have 
induced the lethal photosensitization of both Gram-positive and 
Gram-negative bacteria,  [ 21–24 ]   with enhanced activity upon the 
additional encapsulation of 2 nm gold nanoparticles, attributed 
to an increased dye triplet state production.  [ 22,25,27 ]   Moreover, 
some photobactericidal surfaces also demonstrated signiﬁ  cant 
kill under dark conditions, over long time periods.  [ 34 ]   
  Whereas other bactericidal surfaces lose efﬁ  cacy due to the 
build-up of dirt obscuring the antimicrobial properties, it is antici-
pated that the photogenerated species produced by these samples 
can oxidize organic contaminants on the polymer surface, main-
taining the surface anti-infective properties. Photobactericidal 
polymers have also demonstrated the laser-activated reduction of 
  Staphylococcus epidermidis   bioﬁ  lm formation,  [ 35 ]   a crucial property 
for polymers developed for use in medical devices. However, one 
drawback is that it has proven difﬁ  cult to synthesize aqueously 
dispersed gold nanoparticles within the narrow size constraints 
required for the enhanced antimicrobial efﬁ  cacy and to purchase 
commercially produced gold colloid is relatively expensive. 
  Zinc oxide is a naturally occurring metal oxide; it is inexpen-
sive, has a high thermal conductivity and a wide band gap (3.36 eV) 
lending itself to a large range of commercial applications 
from paint pigmentation to ﬁ   eld effect transistors, gas sen-
sors, and in photovoltaics. Zinc oxide is generally considered 
to be safe and has widespread use as a food additive,  [ 36 ]   in food 
packaging,  [ 37 ]   and in skin ointments. In fact, it is commonly 
used to treat diaper rashes  [ 38,39 ]   and also widely used in sun-
screen products as it is an effective block of UV radiation.  [ 38,40 ]  
Recently, zinc oxide nanoparticles have attracted heightened 
research interest in terms of their semiconductor properties, in 
addition to their bactericidal activity. They exhibit antibacterial 
properties against a range of both Gram-positive and Gram-
negative bacteria through a cytotoxic mechanism, in addition 
to showing activity against high-temperature and -pressure 
resistant spores and fungal pathogens.  [ 41–45 ]   It has been sug-
gested that the mechanism by which zinc oxide nanoparticles 
demonstrate antimicrobial activity may involve the accumula-
tion of nanoparticles in the outer membrane or cytoplasm of 
bacterial cells, or may be attributed to the generation of reac-
tive oxygen species.  [ 45 ]   Reports have also indicated that zinc 
oxide nanoparticles may disrupt or damage bacterial cell mem-
branes, resulting in the leakage of intracellular components, 
or cause oxidative stress.  [ 46,47 ]   Zinc oxide nanoparticles also 
demonstrate an enhanced antimicrobial efﬁ   cacy, when com-
pared to bulk zinc oxide.  [ 42,44 ]   This can be attributed to the high 
surface area to volume ratio of nanoparticles.  [ 42 ]   Moreover, it 
has also been observed that there exists a size dependency on 
the antimicrobial activity of the zinc oxide nanoparticles, with 
decreasing nanoparticle size resulting in greater activity.  [ 41,44,45 ]  
  Since nanoparticulate zinc oxide is insoluble in most sol-
vents, in order to disperse the nanoparticles, large excesses 
of surfactant are often added. However, the presence of sur-
factant can reduce performance. To overcome these adverse 
effects and obviate the need for excess surfactant, a synthetic 
organometallic route to zinc oxide via hydrolysis of zinc alkyl 
groups in the presence of nonhydrolyzable zinc carboxylates 
can be used.  [ 48,49 ]   Recently, it has been noted that the use of 
zinc di(octyl) phosphinate surface groups enhances solubility of 
the nanoparticles, improving its catalytic performance in meth-
anol synthesis.  [ 50 ]   The resultant small zinc oxide nanoparticles 
(3–4 nm) are easily dispersed in toluene and can be encapsu-
lated into polymers using a simple swelling strategy. 
  In this paper, the use of a two-step dipping process to incorpo-
rate zinc oxide nanoparticles in combination with a commercially 
available photosensitizer dye, crystal violet, into medical-grade 
silicone is reported on. In addition to characterization by UV–vis 
absorbance spectroscopy, transmission electron microscopy (TEM) 
was used to analyze the nanoparticle-embedded polymer and 
demonstrated evidence of nanoparticle incorporation. The antimi-
crobial activity of the crystal violet-coated, nanozinc-oxide-encapsu-
lated polymer was tested against both Gram-negative and Gram-
positive bacteria ubiquitous in healthcare settings and a white 
light source comparable to standard hospital lighting conditions 
was used to enhance the antimicrobial properties of the novel 
material. Surprisingly, signiﬁ  cant kill was achieved against both 
bacteria under dark conditions, with a signiﬁ  cant enhancement in 
bactericidal activity demonstrated upon white light illumination.   
  2.      Results 
  2.1.      Material  Synthesis  and  Characterization 
  Novel antimicrobial crystal violet-coated, zinc-oxide-encapsu-
lated silicone polymers were prepared using a simple two-step 
dipping procedure. In the ﬁ  rst dipping step, the silicone poly-
mers were immersed in a ZnO nanoparticle/toluene swelling 
solution (1 mg mL  −1   ZnO nanoparticles) for 24 h, for optimal 
zinc oxide nanoparticle incorporation throughout the polymer 
bulk and no change in polymer coloration was observed upon 
use of the “swell-encapsulation-shrink” strategy. Post-treatment 
with an aqueous crystal violet solution (0.001 mol dm  −3  , 72 h) 
resulted in a purple colored polymer (  Figure     1    ) and as has been 
optimized previously,  [ 26 ]   the uptake of the dye was a predomi-
nantly surface process at this concentration. It should be noted 
that the rate of surface uptake of the dye can be increased and 
reduced to ca. 4 h by heating the dipping solution to 40 °C.   
  UV–vis absorbance spectroscopy analysis of the swelling 
solutions used for sample preparation demonstrated a char-
acteristic shoulder at 350 nm for the dispersed ZnO nano-
particle solution,  [ 50 ]   whereas the capping agent solution and 
Zn(DOPA)  2   exhibited no signiﬁ  cant absorption in this region 
(  Figure     2    a). Using a Tauc plot (see Supporting Information 2.1), 
the band onset of the nanoparticle suspension was estimated at 
3.53 eV (Figure   2  a, inset), indicating that the ZnO nanoparticle 
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is a UV photocatalyst (<385 nm) and should not exhibit signiﬁ  -
cant white light-activated antimicrobial activity. UV–vis absorb-
ance spectroscopy was also used to examine the materials 
prepared for microbiological testing (Figure   2  b). When encap-
sulated in silicone, no characteristic UV–vis signal of the ZnO 
nanoparticles was noted. This can be attributed to low polymer 
nanoparticle concentrations and signiﬁ  cant UV–vis absorption 
signal of the silicone substrate in the region 250–350 nm. The 
UV–vis absorbance signals of both the crystal violet-coated sili-
cone samples and the crystal violet-coated, zinc oxide-embedded 
silicone samples were similar in peak shape and position and 
characteristic of the crystal violet dye, with absorbance maxima 
at   λ   ≈ 590 nm and a shoulder peak at   λ   ≈ 545 nm. This indi-
cates that the presence of the zinc oxide nanoparticles does not 
affect the position of spectral features.   
  X-ray photoelectron spectroscopy (XPS) analysis of the 
nanoparticle powder identiﬁ  es a doublet in the Zn-2p region 
corresponding to zinc in ZnO (see Supporting Information, 
2.2a). XPS of the crystal violet-coated, zinc oxide nanoparticle-
encapsulated silicone polymer showed evidence of nanoparticle 
encapsulation (see 2.2b-e, Supporting Information). A doublet 
in the Zn (2p) region corresponding to zinc in ZnO was identi-
ﬁ  ed, conﬁ  rming the presence of zinc oxide nanoparticles within 
the polymer. Peaks in the O (1s) region, and C (1s) region 
Si (2p) region, and N (1s) region were also present, correlating 
to the presence of the nanoparticle, polymer and crystal violet 
dye (N peak). Inductively coupled plasma-optical emission 
spectroscopy (ICP-OES) was used to determine whether ZnO 
or other zinc species leached from the polymer into solution. 
Samples of silicone embedded with ZnO (1.1 × 1.1 × 0.1 cm) 
were immersed in distilled water and the concentration of 
zinc released into solution, was measured periodically. Results 
indicated that small traces of zinc leached into solution (up to 
0.0025 mg of zinc per sample) over the 3 weeks experimental 
duration (full results in Supporting Information, 2.3). 
  TEM of toluene dispersed zinc oxide nanoparticle powder 
drop cast onto TEM grids shows well-separated, small, spher-
ical nanoparticles with no evidence of agglomeration (  Figure     3  ). 
Size analysis showed an average nanoparticle diameter 
of 3.3 nm (±1.1 nm), which is similar to that calculated from 
the UV–vis. HR-TEM images showed the particles to be crystal-
line with lattice spacings correlating with Wurtzite ZnO. Each 
nanoparticle was composed of a single-crystalline domain, a 
result of the nucleation controlled growth and the prevention 
of oriented attachment by the strongly bound di(octy)phosphi-
nate ligand. TEM analysis of the ZnO nanoparticle-embedded 
polymer edge demonstrated evidence of nanoparticle encapsu-
lation, with visible crystallographic planes present (Figure   3  C). 
Lattice spacings of 0.28 nm were observed correlating to the 
(100) plane of hexagonal ZnO.   
  The photostability of crystal violet- and crystal violet-coated, 
zinc oxide nanoparticle-encapsulated silicone polymers under 
white hospital light source conditions, was examined using 
UV–vis spectroscopy (see Supporting Information, 2.4). The 
crystal violet-coated samples demonstrated strong photostability 
under ambient lighting conditions and even under the intense 
lighting conditions used in this study - 31 x more intense that 
that typical of hospital wards and corridors (ca. 200 lx).  [ 29 ]   The 
photodegradation of the crystal violet-coated silicone polymers 
was ca. 59% over a period of 61 d. Over the same period of 
time, the crystal violet-coated, zinc oxide-encapsulated polymer 
resulted in a 35% photodegradation of the crystal violet dye, 
indicating that the ZnO nanoparticles did not degrade the dye 
and interestingly, the presence of the nanoparticles may in fact 
stabilize the dye with respect to photodegradation. These stabi-
lization effects are an area of interest for future research. These 
samples demonstrate suitability for use as photo-activated 
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  Figure 1.        a) Photograph of the zinc oxide nanoparticle-encapsulated 
silicone sample and the crystal violet-coated, zinc oxide nanoparticle-
encapsulated silicone sample. b) Cross-sectional photograph of the zinc-
oxide nanoparticle encapsulated, crystal violet-coated silicone sample. 
The sample dimensions are 1.1 cm × 1.1 cm × 0.1 cm.
  Figure 2.         a) UV–vis absorbance spectra of toluene-dispersed di(octyl)phosphinic acid-capped zinc oxide nanoparticles (ZnO NP), di(octyl)phosphinic 
acid in toluene (DOPA-H) and zinc bis(di(octyl) phosphinate) (Zn(DOPA)  2  ) in toluene. Inset: Tauc plot to determine bandgap of di(octyl)phosphinic 
acid-capped zinc oxide nanoparticles. The band onset of the 3–4 nm zinc oxide nanoparticles was calculated as 3.53 eV. b) UV–vis absorbance spectra 
of modiﬁ  ed samples used for microbiological testing: Solvent-treated silicone (control), crystal violet-coated-silicone (CV), zinc oxide nanoparticle-
encapsulated-silicone (ZnO) and crystal violet-coated, zinc oxide nanoparticle-encapsulated silicone (CV-ZnO).F
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antimicrobial surfaces under the laboratory testing conditions 
investigated indicating that under ambient lighting in ideal-
ized conditions, these samples would demonstrate long-term 
photostability. It should be noted that in healthcare applications 
where the surfaces are constantly exposed to harsh chemical 
cleaning treatments and there is frequent surface contact, the 
material stability may be reduced, however, it is anticipated that 
these surfaces should maintain potency for several years.   
  2.2.      Microbiological  Testing 
  The antimicrobial activity of a series of modiﬁ  ed  medical-
grade silicone samples was determined using representa-
tive Gram-positive and Gram-negative bacteria,   S. aureus   and 
  E. coli  , respectively, both of which are commonly found in 
healthcare environments. For each experiment, a set of sam-
ples were illuminated with a 28 W white hospital light source, 
emitting an average light intensity of 3750 lux at a distance of 
30 cm, while a parallel set was stored under dark conditions for 
the same duration. Although the white light intensity used in 
this investigation is approximately three times that found in a 
typical A & E examination room,  [ 29 ]   the microbial loads used in 
these experiments far surpass those typically found in a clinical 
environment, to test the potency of these antimicrobial sur-
faces (≈45 529 cfu cm  −2   used in this investigation, compared 
to ≤3060 cfu cm  −2   with average values of <100 cfu cm  −2   in a 
clinical environment  [ 12,13,34,51,52 ] ). 
  The photo-activated and intrinsic bactericidal activities of the 
following samples were tested: solvent-treated silicone, a crystal 
violet-coated silicone (CV), a di(octyl)phosphinic acid-capped 
zinc oxide nanoparticle-encapsulated silicone (ZnO), a di(octyl)-
phosphinic acid-encapsulated silicone (DOPA-H), a zinc 
bis(di(octyl) phosphinate-encapsulated silicone (Zn(DOPA)  2 ), 
and a crystal violet-coated, di(octyl) phosphinic acid-capped 
zinc oxide nanoparticle encapsulated silicone (CVZnO). This 
range of samples was tested to deduce whether it was the 
ZnO nanoparticle, free capping agent or the ZnO-bound cap-
ping agent, that contributed to the antimicrobial activity. 
Samples were also coated with crystal violet dye to estab-
lish whether this enhances bacterial kills and if there exists a 
similar synergistic enhancement in the antimicrobial activity as 
previously established with crystal violet, methylene blue and 
gold nanoparticle combinations encapsulated into medical-
grade polymers.  [ 22,26,27,34 ]  
  Under dark conditions (1 h incubation), neither the ZnO 
sample nor the DOPA-H sample demonstrated signiﬁ  cant 
activity when tested against   S. aureus  , although the Zn(DOPA)  2  
sample induced a statistically signiﬁ  cant reduction in staphy-
lococcal numbers (  P   < 0.001) (  Figure     4    a). The CVZnO sample 
signiﬁ  cantly reduced the number of viable   S. aureus   on the 
sample surface (  P   < 0.001), with enhanced bacterial kills com-
pared to the CV sample. This can be attributed to the higher 
concentration of crystal violet at these sample surfaces due to 
the preswelling treatment in toluene, used to encapsulated 
the ZnO nanoparticles. Illumination of these samples using 
a standard hospital lighting source for just 1 h resulted in 
the lethal photosensitization of   S. aureus   on the CV sample 
(1.69 log kill), with a marked increase in antimicrobial activity 
on the CVZnO sample (  P   < 0.001, 3.36 log kill).   
  A correlation has been noted in the literature between the 
decreasing size of the zinc oxide nanoparticle and its bacteri-
cidal efﬁ  cacy.  [ 41,44,45 ]   In this study, small 3–4 nm ZnO nano-
particles were incorporated into the polymer. These polymers 
exhibited antimicrobial activity against   E. coli  , with a statistically 
signiﬁ  cant reduction in bacterial numbers (1.41 log) following 
incubation for 6 h in the dark (  P   < 0.001, Figure   4  ). ICP-OES 
studies indicated that small traces of zinc species leached from 
the polymer when left in aqueous solution for extended periods. 
However, previous research has shown that leached Zn  2+   ions 
are unlikely to contribute to the antimicrobial activity.  [ 45 ]  
  Illumination of the ZnO sample resulted in enhanced anti-
microbial activity with a 1.9 log reduction in bacterial numbers 
for the same incubation duration. No antimicrobial activity 
was observed on the DOPA-H and Zn(DOPA)  2   samples either 
under dark conditions or with white light illumination for 3 h 
and therefore, these samples were not tested for an extended 
duration of 6 h. CV samples demonstrated a limited, but sta-
tistically signiﬁ   cant bactericidal activity when tested against 
  E. coli   (0.72 log kill, 6 h illumination). This discrepancy between 
the efﬁ  cacy of photodynamic therapy (PDT) against Gram-pos-
itive bacteria and Gram-negative bacteria can be attributed to 
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  Figure 3.         a) TEM of zinc oxide nanoparticles with di(octyl) phosphinate capping ligands, b) HR-TEM of zinc oxide nanoparticle with lattice spacings 
and c) silicone polymer encapsulated with zinc oxide nanoparticles with di(octyl) phosphinate capping ligands. d) Histogram of particle size distribu-
tion of zinc oxide nanoparticles as synthesized, determined by TEM.F
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differences in their cell wall structures.  [ 26 ]   Gram-negative bac-
teria have both an inner and outer cell membrane composed of 
phospholipid bilayers embedded with lipopolysaccharides and 
proteins, whereas Gram-positive bacteria have a single-inner 
phospholipid bilayer cellular membrane surrounded by pep-
tidoglycan and this acts as an ineffective barrier against PDT. 
It has also been noted that the inherent bactericidal efﬁ  cacy of 
crystal violet against Gram-negative bacteria is more limited.  [ 26 ]  
However, the dual-combination CVZnO sample exhibited 
potent photobactericidal activity against   E. coli ,  with  bacterial 
numbers reduced by 2.16 log within 3 h white light illumina-
tion and to below the detection limit in 6 hours (  P   < 0.001). 
This suggests a synergistic effect in the activity of the triaryl-
methane dye when ZnO nanoparticles are present, as enhance-
ments in bacterial kills were noted, that surpassed kills demon-
strated if they were caused by an additive effect. 
  Overall, the results indicate that the ZnO samples demon-
strate a stronger bactericidal activity against the Gram-negative 
bacterium,   E. coli  , than the Gram-positive,   S. aureus .  Con-
versely, the CV samples induce the lethal photosensitization 
of   S. aureus  . Crystal violet is known to exhibit antimicrobial 
activity against Gram-positive bacteria and is used in the treat-
ment of superﬁ   cial wounds and some skin infections.  [ 53–57 ]  
Consequently, this novel ZnO-dye combination creates an anti-
microbial surface on medical-grade silicone, effective against 
both   E. coli   and   S. aureus  . The CVZnO sample demonstrates 
superior antimicrobial activity, inducing the lethal photosensi-
tization of both   S. aureus   and   E. coli  , with high reductions in 
viable bacterial numbers achieved after only 1 h and 6 h illu-
mination, respectively. Moreover, signiﬁ   cant kills were also 
observed under dark conditions and importantly, a highly sig-
niﬁ  cant reduction in   E. coli   numbers (1.70 log) was recorded 
with CVZnO after 6 h incubation. These samples achieved a 
1.16 log greater reduction in bacterial numbers when tested 
against   E. coli   under dark conditions (6 h), compared to our 
previously synthesized most effective samples, which were 
incorporated with methylene blue, crystal violet, and 2 nm gold 
nanoparticles.  [ 34 ]   It is clear that the zinc oxide nanoparticle, dye-
coated silicone samples exhibit stronger antimicrobial activity 
than other dye-nanoparticle samples investigated under dark 
conditions, while their activity is comparable to that demon-
strated by a previously tested multi-dye-nanogold-encapsulated 
silicone  [ 34 ]   under illumination. 
  To validate the antimicrobial effectiveness of these surfaces, 
their photobactericidal activity was compared to other antimi-
crobial systems published in the literature. Limited data have 
been published on the development of photobactericidal poly-
mers. One system details the synthesis of protoporphyrin- and 
zinc protoporphyrin-grafted nylon ﬁ   bers using a white light 
source of intensities ranging from 10 000 to 60 000 lux, to 
activate the antimicrobial properties.  [ 28 ]   When tested against 
  S. aureus   these samples induced the lethal photosensitiza-
tion of bacteria within 30 min, reducing bacterial numbers to 
5.6% on the zinc protoporphyrin sample at a light ﬂ  uence of 
40 000 lx;  [ 28 ]   however, no antimicrobial activity was observed 
when tested against   E. coli   at this light ﬂ  uence.  [ 28 ]   These results 
Adv. Funct. Mater. 2015, 25, 1367–1373
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  Figure 4.         Graph to show the viable counts of bacteria after incubation on modiﬁ  ed silicone polymers exposed to white light illumination: a)   S. aureus  
(1 h illumination), b)   E. coli   (3 h illumination), and c)   E. coli   (6 h illumination). The white light hospital lighting source emitted an average light intensity 
of 3750 ± 250 lux at a distance of 30 cm from the samples indicates where the bacterial counts were reduced to below the detection limit of 100 cfu.F
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highlight the potent light-activated antimicrobial activity dem-
onstrated by the CVZnO surfaces reported here, achieving the 
lethal photosensitization of both   S. aureus   and   E. coli . 
  These antimicrobial polymers can also be compared to other 
antimicrobial surfaces, including visible light photoactive anti-
microbial titania, silver-loaded titania, nitrogen-doped titania, 
and silver-loaded nitrogen-doped titania thin ﬁ  lms on glass sur-
faces.  [ 17,19 ]   Some of these antimicrobial systems demonstrate 
poor antimicrobial efﬁ  cacy compared with the CVZnO silicone 
reported here.  [ 17,28 ]   However, other systems exhibited compa-
rable, or enhanced antimicrobial activity.  [ 11,19 ]   The use of thin-
ﬁ  lm antimicrobial coatings, or copper surfaces however, pre-
sents a substantial ﬁ  nancial burden to healthcare institutions. 
Existing furnishings would have to be replaced with the anti-
microbial equivalent and UK hospitals that are part of the Pri-
vate Finance Initiative scheme would also be required to pay an 
upfront “30 year lifetime cost” for new furnishing installations. 
The use of an antimicrobial polymer that can be retroﬁ  t onto 
existing furnishings presents a promising, inexpensive alterna-
tive for use as an infection-control mechanism. 
  It is anticipated that this crystal violet-zinc oxide-polymer tech-
nology can be utilized to develop antimicrobial surfaces for use, 
chieﬂ  y in healthcare environments, but also in everyday applica-
tions such as keyboards, mobile phone, and tablet covers and 
kitchen surfaces. Although this novel material has been devel-
oped for use in touch surfaces rather than implanted medical 
devices, it is crucial that these surfaces are nontoxic and contact 
with them do not affect adverse reactions. With the widespread 
use of ZnO nanoparticles in the cosmetics and food industry, 
their toxicity has been extensively studied in a number of reports. 
The toxicity of nanoparticles to humans depends on a number of 
factors including their size, shape, route of administration, and 
dosage.  [ 58 ]   These nanoparticles demonstrate low toxicity to mam-
malian cells, with investigations concluding that ZnO nano-
particle penetration through the skin is negligible and through 
other routes of administration ZnO only showed toxic effects at 
high doses (>100 µg mL  −1 ). [ 59–61 ]   Crystal violet also poses a low 
toxicity risk and was used as a topical antiseptic before its use 
was superseded by modern drugs.  [ 62 ]   The World Health Organi-
zation also recommended its inclusion in the “Interagency 
Emergency Health Kit”  [ 63 ]   and clinical trials have investigated its 
efﬁ  cacy as a potential treatment against MRSA.  [ 64,65 ]   However, it 
should be noted that the release of nanoparticles such as copper 
oxide, zinc oxide, and silver, from household products into waste 
streams can pose a threat to “non-target” aquatic organisms.  [ 66 ]  
In this application, the nanoparticles are embedded within a 
polymer, with low leaching concentrations documented and it is 
anticipated that these antimicrobial surfaces would be used in 
“dry” applications and therefore should not pose an additional 
risk to aquatic organisms. Consequently, the use of this antimi-
crobial combination in these novel dual-mechanism antimicro-
bial surfaces should not present a risk to users and should main-
tain low surface bacterial levels, reducing the likelihood of the 
spread of infections in a hospital environment.    
  3.      Conclusion 
 Highly  efﬁ  cacious antimicrobial surfaces have been synthesized 
using a straightforward and simple two-stage dipping process. 
Incorporation of both ZnO nanoparticles and crystal violet dye 
into medical-grade silicone resulted in one of the most effective 
antimicrobial polymer surfaces that has been developed to date. 
This material demonstrates bactericidal activity via a novel dual-
mechanism approach, utilizing PDT in combination with the 
inherent antimicrobial properties of zinc oxide nanoparticles, 
such that the resultant polymer exhibits potent bactericidal 
behavior, with signiﬁ   cant bacterial kills achieved within 1 h 
against Gram-positive bacteria and within 6 h against Gram-
negative bacteria in both dark and illuminated conditions. 
  These antimicrobial materials present ideal surfaces for use 
in healthcare environments. Moreover, it can be speculated that 
due to the multiple bacterial attack mechanisms present associ-
ated with the component antimicrobial agents, bacterial resist-
ance to this novel multiple-mechanism antimicrobial surface is 
unlikely.  
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